A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/404 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2612769
The present invention relates to the formulation of solid dosage forms comprising a therapeutically effective amount of an HMG-CoA reductase inhibitor, and especially Fluvastatin or Atorvastatin or salts thereof, in combination with inorganic silica polymer such as Dimethicone, and a process for the preparation thereof by direct compression.
La présente invention concerne la formulation de formes posologiques solides comprenant une quantité thérapeutiquement suffisante d'inhibiteur de HMG-CoA réductase, et plus particulièrement les fluvastatine ou atorvastatine et certains de leurs sels, en association avec des polymères inorganiques de silice tels que la diméthicone. L'invention concerne également un procédé d'élaboration correspondant par compression directe.
Bikiaris Dimitrios
Karavas Evangelos
Koutris Efthimios
Moffat & Co.
Pharmathen S.a.
LandOfFree
Improved pharmaceutical composition containing hmg-coa... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved pharmaceutical composition containing hmg-coa..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved pharmaceutical composition containing hmg-coa... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1923566